But if I'm not mistaken, the majority of patients will still need to wait for an FDA-approved, government-validated test, before we get any financial coverage for this - or wider acceptance by less-informed physicians, of the test as "legit". Which underscores the importance of advocacy to educate the blood folks and other stakeholders on WHY this is urgent - from a scientific perspective.
And of course we have to wait for causality research. And the media response to XMRV - when embargos are finally lifted - may change the way things unfold.
That should definitely help...but yes, I would think nothing will be covered until both causality can be proven, and an FDA approved test is available.